KELUN PHARMA(SZ:002422) Xin Lang Cai Jing·2025-09-10 02:14Company Overview - Sichuan Kelun Pharmaceutical Co., Ltd. is located at 36 Baihua West Road, Qingyang District, Chengdu, Sichuan Province, established on May 29, 2002, and listed on June 3, 2010. The company primarily engages in the development, production, and sales of large-volume parenteral solutions [1][2]. Financial Performance - For the first half of 2025, Kelun Pharmaceutical reported operating revenue of 9.083 billion yuan, a year-on-year decrease of 23.20%, and a net profit attributable to shareholders of 1.001 billion yuan, down 44.41% year-on-year [2]. - Since its A-share listing, the company has distributed a total of 6.697 billion yuan in dividends, with 3.386 billion yuan distributed over the past three years [3]. Stock Performance - As of September 2, the stock price of Kelun Pharmaceutical increased by 2.04%, reaching 40.93 yuan per share, with a trading volume of 229 million yuan and a turnover rate of 0.43%, resulting in a total market capitalization of 65.408 billion yuan [1]. - Year-to-date, the stock price has risen by 39.08%, with a 7.15% increase over the last five trading days, a 9.00% increase over the last 20 days, and a 6.59% increase over the last 60 days [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders increased to 34,200, up by 2.55%, with an average of 38,138 circulating shares per person, a decrease of 2.49% [2]. - The top ten circulating shareholders include notable funds such as China Europe Medical Health Mixed A and Hong Kong Central Clearing Limited, with varying changes in their holdings [3].